WASHINGTON, DC — Recently, IPCPR President Finnie Helmuth, 1st Vice President Craig Cass, and others met with the Office of Management and Budget Office of Information and Regulatory Affairs (OIRA) to discuss the FDA’s proposal to regulate premium cigars under the Tobacco Control Act. While we do not know what the rule contains, we remain vigilant to any provision that has implications on how you conduct business as a premium cigar retailer.
As a follow-up to that meeting, IPCPR’s counsel for FDA affairs, Dave Clissold of Hyman Phelps, prepared the attached letter for IPCPR’s Federal Affairs Committee in conjunction with CRA and sent it to the Administrator of OIRA, Howard Shelanski. This letter outlines the argument why premium cigars do not fit the scope of the Tobacco Control Act because they are not habitual and are not desirable, affordable, or accessible to America’s youth.
IPCPR is continuing the fight to keep the FDA out of your humidor. If you have not already, please contact your Member of Congress to urge support of H.R. 792 & S. 772. More information can be found at www.ipcpr.org.
If you have any questions, please contact Senior Director of Federal Legislative Affairs, Kip Talley (firstname.lastname@example.org), for more information.